balance
play

Balance chronic pain management and responsible opioid prescribing - PowerPoint PPT Presentation

Balance chronic pain management and responsible opioid prescribing Michelle Bardack, M.D. Family & Community Medicine April 27, 2011 Overview Frame the dilemma Federation of State Medical Boards Discussion and questions Opioid


  1. Balance chronic pain management and responsible opioid prescribing Michelle Bardack, M.D. Family & Community Medicine April 27, 2011

  2. Overview • Frame the dilemma • Federation of State Medical Boards • Discussion and questions Opioid – Narcotic Discussion 2 April 27, 2011

  3. United States Statistics • 70 - 100 million adults have chronic pain 1 • 5 -33% of outpatient visits to primary care clinics 2 • Unrelieved pain is a public health epidemic • 2003 JAMA published overall costs to society of $61 billion 3 , similar to that of cancer and CVD 4 Opioid – Narcotic Discussion 3 April 27, 2011

  4. It’s the law! 2005 - WHO “…relief of pain is a basic human right…” 5 JCAHO “….Patients have the right to appropriate assessment and management of pain….” 6 Pain Relief Act NM January 20, 2003, “….every New Mexican shall receive appropriate treatment for pain,” further, “….health providers have an obligation to treat chronic pain….including the use of controlled substances…” 7 Opioid – Narcotic Discussion 4 April 27, 2011

  5. Categories of Pain Treatment • Psychological approach - CBT, Biofeedback, hypnosis • Injection - TPI, ESI, joint • Neural blockade - celiac plexus block • Implants - intrathecal pump, nerve stimulator • Surgical - cordotomy, neurotomy • Non-opioid drugs - NSAIDS, acetaminophen • Adjuvant analgesics - antidepressants, anticonvulsants • Rehabilitative approaches - hot/cold packs, nerve stim, PT/OT • CAM - acupuncture, chiropractic, massage • Lifestyle changes - Etoh, tobacco, sedentary life, wt loss • Opioids - morphine, oxycodone, fentanyl, methadone Opioid – Narcotic Discussion 5 April 27, 2011

  6. Fear influences us Last week’s JAMA: Opioid overdose is now the second leading cause of unintentional death in the USA 8 The 'Oxy Express': Florida's Drug Abuse Epidemic NPR Morning Edition , March 14, 2011 9 " If you're a clinic owner or a doctor or an employee knowingly working at one of these pill mills, we have probably bought dope from you. And we are probably coming to see you soon.” 10 Opioid – Narcotic Discussion 6 April 27, 2011

  7. Drug Deaths in New Mexico 11 2002 2003 % Change Total drug overdose deaths 253 307 21 Rx drug overdose deaths 66 108 64 Illicit drug overdose deaths 187 199 6 Morphine/heroin 133 (55%) 121 (44%) -9 Cocaine 94 (39%) 110 (40%) 17 Alcohol 76 (31%) 78 (28%) 3 Methadone 28 (11%) 34 (12%) 21 Oxycodone 14 (6%) 26 (9%) 86 Methamphetamine 11 (5%) 21 (8%) 91 Propoxyphene 10 (4%) 18 (6%) 80 Diazepam 12 (5%) 16 (6%) 33 Table 1. The Most Common Hydrocodone 18 (7%) 15 (5%) -17 Drugs Causing Death Among Total Drug Overdose Deaths in Amitriptyline 8 (3%) 14 (5%) 75 New Mexico, 2002-2003 Fentanyl 2 (1%) 8 (3%) 300 Opioid – Narcotic Discussion 7 April 27, 2011

  8. DILEMMA How do we responsibly prescribe opioids and balance management of chronic pain? Opioid – Narcotic Discussion Opiophobia 12 8 April 27, 2011

  9. A New Approach You will no longer cringe, hide head in the sand Rewarding for patient and provider Opioid – Narcotic Discussion 9 April 27, 2011

  10. Opioid history 1. One of the oldest known drugs - opium 2. Appeared in Europe and US in 1800s, — 1890’s 1st Congressional Act --opium taxed — 1914 Harrison Tax Act--criminalized non-clinical use 3. Where we are today: – Controlled Substances Act 1970’s (CSA) – Schedule classification (Class I - V) Opioid – Narcotic Discussion 10 April 27, 2011

  11. Pharmacology 1. Mechanism of action: mu-opioid receptor – Highly variable receptor with a range of responses - producing wide inter-individual variations 2. Types: short, long, rapid-acting 3. Common side effects – nausea – sedation – constipation – pruritu s Opioid – Narcotic Discussion 11 April 27, 2011

  12. Which one to choose? An opioid trial is the only way a clinician can determine the efficacy and tolerability of a particular agent in a particular a patient 13 Opioid – Narcotic Discussion 12 April 27, 2011

  13. What are barriers to prescribing? Patient 14 Doctor 14 Regulatory 15 Opioid – Narcotic Discussion 13 April 27, 2011

  14. Barriers Patient barriers • Patient: Fear if adverse affects • Fear that pain is irreversible and inevitable • Fear of addiction • Fear of focusing on symptoms and not cause Opioid – Narcotic Discussion 14 April 27, 2011

  15. Barriers Doctor barriers = opiophobia – Lack of education about opioids and current standards – Fear of toxicity – Fear of addiction – Fear of being “scammed or had” by patient – Fear of regulatory scrutiny Opioid – Narcotic Discussion 15 April 27, 2011

  16. Regulatory Barriers 1. States laws restrict Schedule II – prescription quantity or duration – prescription validity period 2. Prescription series 3. Triplicates/duplicates 4. Prescription monitoring programs Opioid – Narcotic Discussion 16 April 27, 2011

  17. Federation of State Medical Boards (FSMB) 2005 Seven Step Process 1. Patient evaluation 2. Treatment plan 3. Informed consent and agreement (contract) 4. Periodic review 5. Consultation 6. Documentation 7. Compliance with controlled substances laws and regulations Opioid – Narcotic Discussion 17 April 27, 2011

  18. Step 1 Patient evaluation – Document H & P – Comorbidities - anxiety, depression, cancer – History of substance abuse - CAGE, ORT – Document the indication for opioid use Opioid – Narcotic Discussion 18 April 27, 2011

  19. Step 2 Treatment plan – Objectives – Adjust over time – Don’t forget other modalities Opioid – Narcotic Discussion 19 April 27, 2011

  20. Step 3 Informed consent and agreement contract – Discuss – Document – Contract – Violation Opioid – Narcotic Discussion 20 April 27, 2011

  21. Step 4 Periodic review – Evaluate progress toward treatment objective – FOUR A’s - analgesia, activities, adverse effects, aberrant behaviors 16 – Satisfactory response – “Zero pain” vs improved quality of life Opioid – Narcotic Discussion 21 April 27, 2011

  22. Step 5 Consultation – Be willing to refer patients at risk • Misuse, abuse, or diversion • Substance abuse • Psychiatric disorder Opioid – Narcotic Discussion 22 April 27, 2011

  23. Step 6 - Documentation Accurate and complete medical records – Treatment objective – Discussion of risks and benefits – Informed consent – Treatments – Past tried, why failed; Current; Future ideas – Medications: – Date, type, dosage, and quantity – Instructions and agreements – Periodic reviews Opioid – Narcotic Discussion 23 April 27, 2011

  24. Step 7 Regulations – Licensed in the state you are prescribing – Federal regulations www.usdoj.gov/dea – State regulations www.nmmb.state.nm.us https://www.pmp.state.nm.us/pmp/webcenter Opioid – Narcotic Discussion 24 April 27, 2011

  25. Vocabulary Physical Dependence - a state of adaptation that is manifested by drug class-specific signs and symptoms that can be produced by abrupt cessation, rapid dose reduction, decreasing blood level of the drug and/or administration of antagonist, physical dependence, by itself, does not equate with addiction Opioid – Narcotic Discussion 25 April 27, 2011

  26. Vocabulary Pseudoaddiction - iatrogenic syndrome from the misinterpretation of relief seeking behavior as though they are drug -seeking behaviors that are commonly seen in addiction. BUT relief of seeking behavior resolves with the institution of effective analgesia Opioid – Narcotic Discussion 26 April 27, 2011

  27. Vocabulary Substance Abuse - use of a substance for non therapeutic purposes or use of medication for purposes other than those it was prescribed for Tolerance - a physiologic state resulting from regular use of a drug in which an increased dosage is needed to produce a specific effect or a reduced effect is observed with a constant dose over time. Tolerance may or may not be evident during opioid treatment and does not equate with addiction. Opioid – Narcotic Discussion 27 April 27, 2011

  28. Finally Public Multiple focus areas Health for scholarly National/ Individual International project/publication Health Regulations Government Public State Policy Pharmaceutical Companies Opioid – Narcotic Discussion 28 April 27, 2011

  29. Websites 2005 National survey on drug use and health www.oas.samhsa.gov University of Wisconsin – Pain Policy www.painpolicy.wisc.edu New England Journal of Medicine – Opioid http://www.nejm.org/search?q=opioid+therapy+for+chronic+pain&asug=opio National Alliance Of Advocates - Buprenorphine Treatment http://www.naabt.org/laws.cfm Opioid – Narcotic Discussion 29 April 27, 2011

Download Presentation
Download Policy: The content available on the website is offered to you 'AS IS' for your personal information and use only. It cannot be commercialized, licensed, or distributed on other websites without prior consent from the author. To download a presentation, simply click this link. If you encounter any difficulties during the download process, it's possible that the publisher has removed the file from their server.

Recommend


More recommend